Treatment of Progressive Multifocal Leukoencephalopathy With Mirtazapine.

Yvan JamillouxSébastien KereverTristan FerryChristiane BroussolleJérôme HonnoratPascal Sève

Published in: Clinical drug investigation (2017)

Except for natalizumab-associated PML, we did not highlight any potential benefit of mirtazapine on disease outcomes. Further interventional studies are needed to confirm that 5-HT2AR inhibition is relevant to treat PML.

Keyphrases

multiple sclerosis
case control
risk assessment
metabolic syndrome
climate change
skeletal muscle
weight loss